venture capital firm

View All

Peloton Therapeutics
Neurogene raises $68.5M; AbbVie and Teneobio sign deal; 5AM Ventures nets

Neurogene raises USD 68.5 Million for rare neurological diseases Neurogene netted USD 68.5 million to advance multiple gene therapy programs in its series A round. The idea is to take its major programs into IND-enabling studies for Aspartylglucosaminuria (AGU) and a rare form of Charcot-Marie Tooth disease with...

Find More